Two recent studies have explored the effectiveness of quaternary ammonium compounds (QACs) in combating MRSA infections. The first study conducted by researchers at a university laboratory tested various QACs against MRSA strains and found that certain compounds were highly effective at killing the bacteria. The researchers used a combination of in vitro experiments and animal models to demonstrate the efficacy of QACs in treating MRSA infections. The second study, conducted in a hospital setting, evaluated the use of QAC-based disinfectants in reducing MRSA transmission among patients. The results showed a significant decrease in MRSA colonization rates in patients treated with QAC-based disinfectants compared to those who were not. These findings suggest that QACs have the potential to be a valuable tool in the fight against MRSA infections in both clinical and hospital settings.